Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Douglas N Fish

Showing results (1-10 of 80) with videos related to

Pageof 8
Sort By:
American Journal of Respiratory and Critical Care Medicine|December 4, 2003
Bronchoscopic sampling of drug concentrations: penetration to tissue is the issueDouglas N Fish
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|April 27, 2005
Telithromycin: do we really need this antimicrobial?Douglas N Fish
Expert Review of Anti-Infective Therapy|October 16, 2004
Levofloxacin: update and perspectives on one of the original 'respiratory quinolones'Douglas N Fish
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|March 12, 2002
Optimal antimicrobial therapy for sepsisDouglas N Fish
International Journal of Antimicrobial Agents|April 17, 2007
Evaluation of gatifloxacin pharmacokinetics and pharmacodynamics in severely ill adults in a medical Intensive Care UnitDouglas N Fish
Therapeutics and Clinical Risk Management|March 25, 2008
Meropenem in the treatment of complicated skin and soft tissue infectionsDouglas N Fish
Pharmacotherapy|June 8, 2013
Correlation of pharmacokinetic/pharmacodynamic-derived predictions of antibiotic efficacy with clinical outcomes in severely ill patients with Pseudomonas aeruginosa pneumoniaDouglas N Fish, Tyree H Kiser
Critical Care Clinics|May 9, 2006
Antimicrobial resistance: factors and outcomesDouglas N Fish, Martin J Ohlinger
Pharmacotherapy|December 21, 2002
Pharmacology, clinical efficacy, and safety of drotrecogin alfa (activated)Maria I Rudis, Douglas N Fish
Pharmacotherapy|March 24, 2006
Evaluation of bivalirudin treatment for heparin-induced thrombocytopenia in critically ill patients with hepatic and/or renal dysfunctionTyree H Kiser, Douglas N Fish
Pageof 8

Showing results (1-10 of 80) with videos related to

Sort By:
Pageof 8
American Journal of Respiratory and Critical Care Medicine|December 4, 2003
Bronchoscopic sampling of drug concentrations: penetration to tissue is the issueDouglas N Fish
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|April 27, 2005
Telithromycin: do we really need this antimicrobial?Douglas N Fish
Expert Review of Anti-Infective Therapy|October 16, 2004
Levofloxacin: update and perspectives on one of the original 'respiratory quinolones'Douglas N Fish
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|March 12, 2002
Optimal antimicrobial therapy for sepsisDouglas N Fish
International Journal of Antimicrobial Agents|April 17, 2007
Evaluation of gatifloxacin pharmacokinetics and pharmacodynamics in severely ill adults in a medical Intensive Care UnitDouglas N Fish
Therapeutics and Clinical Risk Management|March 25, 2008
Meropenem in the treatment of complicated skin and soft tissue infectionsDouglas N Fish
Pharmacotherapy|June 8, 2013
Correlation of pharmacokinetic/pharmacodynamic-derived predictions of antibiotic efficacy with clinical outcomes in severely ill patients with Pseudomonas aeruginosa pneumoniaDouglas N Fish, Tyree H Kiser
Critical Care Clinics|May 9, 2006
Antimicrobial resistance: factors and outcomesDouglas N Fish, Martin J Ohlinger
Pharmacotherapy|December 21, 2002
Pharmacology, clinical efficacy, and safety of drotrecogin alfa (activated)Maria I Rudis, Douglas N Fish
Pharmacotherapy|March 24, 2006
Evaluation of bivalirudin treatment for heparin-induced thrombocytopenia in critically ill patients with hepatic and/or renal dysfunctionTyree H Kiser, Douglas N Fish
Pageof 8